UA99259C2 - Лечение ожирения антагонистами мускаринового рецептора м1 - Google Patents

Лечение ожирения антагонистами мускаринового рецептора м1

Info

Publication number
UA99259C2
UA99259C2 UAA200900269A UAA200900269A UA99259C2 UA 99259 C2 UA99259 C2 UA 99259C2 UA A200900269 A UAA200900269 A UA A200900269A UA A200900269 A UAA200900269 A UA A200900269A UA 99259 C2 UA99259 C2 UA 99259C2
Authority
UA
Ukraine
Prior art keywords
mantagonist
acetylcholine receptor
muscarinic acetylcholine
treating obesity
antagonists
Prior art date
Application number
UAA200900269A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Брайан СИД
Джордан Мечаник
Original Assignee
Теракос, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Теракос, Инк. filed Critical Теракос, Инк.
Publication of UA99259C2 publication Critical patent/UA99259C2/ru

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
UAA200900269A 2006-06-16 2007-06-15 Лечение ожирения антагонистами мускаринового рецептора м1 UA99259C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80506606P 2006-06-16 2006-06-16

Publications (1)

Publication Number Publication Date
UA99259C2 true UA99259C2 (ru) 2012-08-10

Family

ID=40829458

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200900269A UA99259C2 (ru) 2006-06-16 2007-06-15 Лечение ожирения антагонистами мускаринового рецептора м1
UAA200900268A UA98938C2 (ru) 2006-06-16 2007-06-15 Лечение психологических состояний с применением антагонистов мускариновых рецепторов м1

Family Applications After (1)

Application Number Title Priority Date Filing Date
UAA200900268A UA98938C2 (ru) 2006-06-16 2007-06-15 Лечение психологических состояний с применением антагонистов мускариновых рецепторов м1

Country Status (2)

Country Link
CN (2) CN101472571B (zh)
UA (2) UA99259C2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8748419B2 (en) 2006-06-16 2014-06-10 Theracos, Inc. Treating obesity with muscarinic receptor M1 antagonists
US7893053B2 (en) 2006-06-16 2011-02-22 Theracos, Inc. Treating psychological conditions using muscarinic receptor M1 antagonists
WO2012055018A1 (en) * 2010-10-25 2012-05-03 University Of Manitoba Therapeutic compositions for diabetic symmetrical polyneuropathy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953430A (en) * 1975-02-24 1976-04-27 American Cyanamid Company Substituted benzodiazepin-10-ones and method of use
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US6803357B1 (en) * 1998-02-02 2004-10-12 New England Medical Center Hospitals, Inc. Method of regulating glucose metabolism, and reagents related thereto
WO2002022579A2 (en) * 2000-09-11 2002-03-21 Sepracor, Inc. Antipsychotic sulfonamide-heterocycles, and methods of use thereof
JP4175113B2 (ja) * 2001-03-14 2008-11-05 小野薬品工業株式会社 Ｅｐ１アンタゴニストを有効成分として含有するうつ病の治療剤
WO2004078113A2 (en) * 2003-03-04 2004-09-16 Pharmacia Corporation Treatment and prevention of obesity with cox-2 inhibitors alone or in combination with weight-loss agents
EP1737454A4 (en) * 2004-04-22 2007-08-08 Mor Research Applic Ltd METHOD OF MANAGING FOOD RECOVERY

Also Published As

Publication number Publication date
CN101472571B (zh) 2012-11-14
CN101472476A (zh) 2009-07-01
UA98938C2 (ru) 2012-07-10
CN101472571A (zh) 2009-07-01
CN101472476B (zh) 2013-10-30

Similar Documents

Publication Publication Date Title
WO2009050136A3 (en) Glucocorticoid receptor antagonists such as mifepristone for treating cushing' s syndrome
EP2056818A4 (en) COMPOSITIONS AND METHODS FOR NEUROPROTECTION
EP2478907A3 (en) Methods and compositions for treating cancer
MX2010002781A (es) Combinacion novedosa de angentes terapeuticos.
WO2008024485A3 (en) Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent
EP2032127A4 (en) TREATMENT OF PSYCHOLOGICAL PATHOLOGIES USING M1 MUSCARINIC RECEPTOR ANTAGONISTS
WO2007098113A3 (en) Ccr3 inhibition for ocular angiogenesis and macular degeneration
WO2006015259A3 (en) Compounds and compositions as modulators of steroid hormone nuclear receptors
UA94909C2 (ru) Фармацевтическая композиция нейроактивного стероида и ее применение
WO2007121483A3 (en) Pre-mixed, ready-to-use iv bolus compositions and methods of use
BRPI0510170B8 (pt) composto, composição farmacêutica para o tratamento de doenças mediadas pelo receptor muscarínico de acetilcolina e uso do composto
WO2006055752A3 (en) INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1 AND METHODS OF USING THE SAME
WO2006036770A3 (en) Combination therapy for the treatment of obesity
WO2004110368A3 (en) Combination therapy for the treatment of hypertension
WO2006135638A3 (en) Tanaproget compositions containing ethinyl estradiol
WO2006058059A3 (en) Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject
WO2009140642A3 (en) Tricyclic antagonists of prostaglandin d2 receptors
WO2006065722A3 (en) Compositions and methods for pulmonary conditions
WO2007051062A3 (en) Substituted dihydropyridines and methods of use
WO2005077968A3 (en) 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
WO2007048026A3 (en) Cgrp peptide antagonists and conjugates
NZ588913A (en) Liver cancer drug
MY184864A (en) Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
CL2007003266A1 (es) Compuestos derivados de progesterona, antagonistas del receptor de progesterona; composicion farmaceutica; y uso para el tratamiento de endometriosis, miomas o tumores dependientes de hormonas.
WO2008023362A3 (en) Use of a combination of methotrexate and an a3ar agonist for the treatment of cancer